S. Momsen Reincke - Concepedia

Author

S. Momsen Reincke

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Momsen Reincke, Reincke, S. Momsen, S Momsen Reincke, S. Momsen Reincke, Sebastian Momsen Reincke

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin German Center for Neurodegenerative Diseases Freie Universität Berlin Humboldt-Universität zu Berlin Berlin Institute of Health at Charité - Universitätsmedizin Berlin

About

S. Momsen Reincke is an author at Charité - Universitätsmedizin Berlin specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	483
2	Immunology	7	7	483
3	Health Sciences	1	1	45
4	Social Sciences	1	1	52
5	Cell Biology	1	1	113

S. Momsen Reincke

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants Meng Yuan, Deli Huang, Chang‐Chun D. Lee, Science	2021	409
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model Jakob Kreye, S. Momsen Reincke, Hans‐Christian Kornau, Cell	2020	380
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms Christiana Franke, Caroline Ferse, Jakob Kreye, Brain Behavior and Immunity	2020	260
Subunit composition of <scp>VRAC</scp> channels determines substrate specificity and cellular resistance to <scp>P</scp> t‐based anti‐cancer drugs Rosa Planells‐Cases, Darius Lutter, Charlotte Guyader, The EMBO Journal	2015	251
Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells S. Momsen Reincke, Niels von Wardenburg, Marie A. Homeyer, Cell Autoimmune DiseaseAutoantibody ProductionMedicineT-regulatory CellImmunology	2023	113
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies S. Momsen Reincke, Meng Yuan, Hans‐Christian Kornau, Science VaccinationRbd RidgeVaccine DevelopmentBeta VariantReduced Cross-neutralization	2022	89
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants Meng Yuan, Deli Huang, Chang‐Chun D. Lee,	2021	70
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection Hejun Liu, Meng Yuan, Deli Huang, Cell Host & Microbe VaccinationSars-cov Pseudovirus InfectionVaccine TargetImmunologyVirology	2021	68
Inactivation and Anion Selectivity of Volume-regulated Anion Channels (VRACs) Depend on C-terminal Residues of the First Extracellular Loop Florian Ullrich, S. Momsen Reincke, Felizia K. Voss, Journal of Biological Chemistry	2016	64
Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis Franziska Scheibe, Lennard Ostendorf, S. Momsen Reincke, Journal of Neurology Daratumumab TreatmentAutoimmune DiseaseImmunologyImmune Checkpoint InhibitorPharmacotherapy	2019	62

Page 1